NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026
Nanobiotix, a late-clinical stage biotechnology company specializing in nanoparticle-based cancer treatments and other diseases, announced it will report its financial results for Q4 and full year 2025 on March 31, 2026. The results will be followed by a conference call and webcast on April 1, 2026, where company executives will provide a business …